Clinical trial on changes in 25OHD3 level and vitamin D metabolites level in urine under the condition of increasing serum 25OHD level
Not Applicable
- Conditions
- Healthy Adult
- Registration Number
- JPRN-UMIN000040867
- Lead Sponsor
- FANCL Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
1) Subjects who have digestive system disease, renal disease, liver functional disease, metabolic disease 2) Subjects who take medication during study period (excluding anti-allergic agents) 3) Subjects who have taken vitamin D supplements since June this year 4) Subjects who have gelatin allergy 5) Subjects with difficulty in maintaining direct sunlight exposure for less than 30 minutes a day for 1 week 6) Subjects who smoke habitually 7) Others who are judged to be inappropriate for participation in this test by the test director
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in 25OHD3 and vitamin D metabolite levels in urine
- Secondary Outcome Measures
Name Time Method